Literature DB >> 3019194

Respiratory clearance of 99mTc-DTPA and pulmonary involvement in sarcoidosis.

D J Dusser, M A Collignon, G Stanislas-Leguern, L G Barritault, J Chrétien, G J Huchon.   

Abstract

To investigate the relationships between the respiratory epithelial clearance of micronic aerosolized 99mTc-DTPA (RC-DTPA) and pulmonary function, serum angiotensin-converting enzyme (SACE), and lymphocytic alveolitis in patients with sarcoidosis, RC-DTPA was measured in 49 nonsmokers with pulmonary sarcoidosis and 38 normal nonsmokers. Pulmonary involvement was evaluated on chest roentgenograms (type O = normal, type I = hilar adenopathies, type II = hilar adenopathies associated with parenchymal shadows, type III = parenchymal shadows without adenopathy) and by pulmonary function tests. Serum angiotensin-converting enzyme was determined, and a bronchoalveolar lavage was performed for alveolar lymphocyte differential counting (Ly%). RC-DTPA was increased (greater than or equal to 1.96%/min) in 12 of 31 patients with type II or III involvement but was normal in all 18 patients with type O or I involvement (p = 0.002). Patients with increased RC-DTPA had low FVC, TLC, FEV1, and resting Pao2 (p less than 0.05); resting and exercise AaPo2 were increased (p less than 0.05), but RC-DTPA correlated negatively with FEV1 (p less than 0.01), Pao2 at rest (p less than 0.005), and DLCO (p less than 0.05) and positively with resting and exercise AaPO2 (p less than 0.01). In patients with increased RC-DTPA (42 +/- 17%), Ly% did not differ from Ly% in patients with normal RC-DTPA (34 +/- 16%). SACE was increased in patients with increased RC-DTPA (56 +/- 26 U/ml versus 38 +/- 16 U/ml; p = 0.007) and correlated positively with RC-DTPA (p less than 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3019194     DOI: 10.1164/arrd.1986.134.3.493

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  9 in total

Review 1.  The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Introduction.

Authors: 
Journal:  Thorax       Date:  1999-04       Impact factor: 9.139

2.  Difference in pulmonary absorption of inhaled terbutaline in healthy smokers and non-smokers.

Authors:  B Schmekel; L Borgström; P Wollmer
Journal:  Thorax       Date:  1991-04       Impact factor: 9.139

3.  Pulmonary (99m)Tc-DTPA aerosol clearance and survival in usual interstitial pneumonia (UIP).

Authors:  N Mogulkoc; M H Brutsche; P W Bishop; B Murby; M S Greaves; A W Horrocks; M Wilson; C McCullough; M Prescott; J J Egan
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

4.  Different kinetics of lung clearance of technetium-99m labelled diethylene triamine penta-acetic acid in patients with sarcoidosis and smokers.

Authors:  I Brådvik; P Wollmer; E Evander; H Lárusdóttir; B Blom-Bülow; B Jonson
Journal:  Eur J Nucl Med       Date:  1994-11

5.  Binding and diffusion characteristics of 14C EDTA and 99mTc DTPA in respiratory tract mucus glycoprotein from patients with chronic bronchitis.

Authors:  M S Cheema; S Groth; C Marriott
Journal:  Thorax       Date:  1988-09       Impact factor: 9.139

6.  99mTc-DTPA clearance measured by a dual head gamma camera in healthy subjects and patients with sarcoidosis. Studies of reproducibility and relation to bronchoalveolar lavage findings.

Authors:  S Thunberg; K Larsson; A Eklund; E Blaschke
Journal:  Eur J Nucl Med       Date:  1989

Review 7.  Pulmonary technetium-99m diethylene triamine penta-acetic acid aerosol clearance as an index of lung injury.

Authors:  M J O'Doherty; A M Peters
Journal:  Eur J Nucl Med       Date:  1997-01

Review 8.  Pulmonary nuclear medicine.

Authors:  R F Miller; M J O'Doherty
Journal:  Eur J Nucl Med       Date:  1992

Review 9.  Diffuse lung disease: combined clinical and laboratory studies.

Authors:  R M du Bois
Journal:  J R Coll Physicians Lond       Date:  1994 Jul-Aug
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.